Filter News
Area of Research
News Topics
- (-) Coronavirus (25)
- (-) Physics (13)
- 3-D Printing/Advanced Manufacturing (28)
- Advanced Reactors (14)
- Artificial Intelligence (8)
- Big Data (11)
- Bioenergy (13)
- Biology (5)
- Biomedical (22)
- Biotechnology (2)
- Buildings (1)
- Chemical Sciences (5)
- Clean Water (2)
- Composites (1)
- Computer Science (39)
- Critical Materials (2)
- Cybersecurity (4)
- Energy Storage (21)
- Environment (29)
- Exascale Computing (3)
- Frontier (1)
- Fusion (13)
- Grid (7)
- High-Performance Computing (3)
- Isotopes (8)
- Machine Learning (8)
- Materials (2)
- Materials Science (37)
- Mathematics (2)
- Mercury (1)
- Microscopy (8)
- Molten Salt (2)
- Nanotechnology (17)
- National Security (2)
- Neutron Science (35)
- Nuclear Energy (31)
- Polymers (7)
- Quantum Science (14)
- Security (3)
- Space Exploration (2)
- Summit (17)
- Transportation (15)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 10 of 38 Results

Marcel Demarteau is director of the Physics Division at the Department of Energy’s 91°µÍø. For topics from nuclear structure to astrophysics, he shapes ORNL’s physics research agenda.

Six scientists at the Department of Energy’s 91°µÍø were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.

A new study clears up a discrepancy regarding the biggest contributor of unwanted background signals in specialized detectors of neutrinos.

The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial

A multi-institutional team, led by a group of investigators at 91°µÍø, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.

Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.

ORNL has added 10 virtual tours to its campus map, each with multiple views to show floor plans, rotating dollhouse views and 360-degree navigation. As a user travels through a map, pop-out informational windows deliver facts, videos, graphics and links to other related content.

NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s 91°µÍø that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.

To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A collaboration between the ORNL and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.